Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now LSE - Delayed Quote • USD Intellia Therapeutics, Inc. (0JBU.L) Follow Add holdings 9.20 +0.55 +(6.36%) At close: May 2 at 7:10:11 PM GMT+1 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 0JBU.L 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 0JBU.L View More All News Press Releases SEC Filings Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline Intellia Therapeutics, Inc. (NTLA) Recently Broke Out Above the 50-Day Moving Average Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought Wall Street Analysts Think Intellia Therapeutics (NTLA) Could Surge 392.81%: Read This Before Placing a Bet Trump’s FDA Sends a Bullish Signal to Biotech Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple Intellia doses first subject in trial of nex-z for hereditary ATTRv-PN Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility